Table 1 Baseline characteristics by risk group
High risk | Low risk | p-value | |
|---|---|---|---|
N | 435 | 400 | |
Gender (% female) | 62.8 | 67.0 | 0.20 |
Age (yr) | 58.9 ± 10.5 | 59.9 ± 11.8 | 0.20 |
Race (% AA) | 51.4 | 52.5 | 0.75 |
Diabetes duration (yr) | 14.1 ± 9.7 | 17.2 ± 8.7 | < 0.01 |
HbA1c (%) | 7.7 ± 1.9 | 7.8 ± 2.0 | 0.46 |
Systolic BP (mm Hg) | 135.4 ± 17.8 | 134.2 ± 19.7 | 0.36 |
Diastolic BP (mm Hg) | 75.9 ± 11.6 | 74.7 ± 11.9 | 0.14 |
Serum creatinine (mg/dl) | 1.05 ± 0.37 | 0.97 ± 0.25 | <0.01 |
eGFR creat (ml/min/1.73 m 2 ) | 74.3 ± 27.7 | 76.1 ± 24.3 | 0.32 |
Serum cystatin C (mg/dl) | 1.1 ± 0.3 | 1.0 ± 0.5 | <0.01 |
eGFR creat+cysC (ml/min/1.73 m 2 ) | 73.9 ± 29.3 | 77.4 ± 24.1 | 0.06 |
Urine alb:creat (mg/g) | 27.6 (9-119) | 11.2 (6-22) | <0.01 |
BP meds (%) | 77.7 | 81.6 | 0.16 |
ACE inhibitor (%) | 48.5 | 52.8 | 0.21 |
ARB (%) | 14.1 | 14.8 | 0.77 |
Other BP meds (%) | 57.3 | 57.4 | 0.98 |
Insulin (%) | 45.8 | 42.9 | 0.26 |
Oral hypoglycemic agents (%) | 61.0 | 65.6 | 0.06 |
Lipid-lowering agents (%) | 64.2 | 70.2 | 0.01 |